PIH Health Hospital - Whittier is a hospital in Whittier, California. It is a state-of-the-art facility with 548 licensed beds. Founded in 1959 as Presbyterian Intercommunity Hospital, it has been managed by the nonprofit InterHealth Corporation since the mid-1980s.

There are 548 beds in PIH Health.

During the past decade, PIH Health conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PIH Health" #1 sponsor was "G1 Therapeutics, Inc." with 2 trials, followed by "American Society of Clinical Oncology" with 1 trials sponsored, "Cardiff Oncology" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Jonsson Comprehensive Cancer Center" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PIH Health" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Translational Research in Oncology-U.S" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "PIH Health" are "Triple Negative Breast Cancer" (3 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Coronavirus" (1 trials) and "Diabetic Foot Infection" (1 trials). Many other conditions were trialed in "PIH Health" in a lesser frequency.

Most popular intervention types in "PIH Health" are "Drug" (7 trials), "Biological" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Trilaciclib" (2 trials), "Anastrozole" (1 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin (Investigator discretion)" (1 trials). Other intervention names were less common.

The vast majority of trials in "PIH Health" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "PIH Health". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in PIH Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PIH Health, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".